Predictmedix(TSE:QAI)
CA$0.04+0.01 (+40.00%)
TSE:QAI
Predictmedix financials statements
CA$0.04
At close:+0.01 (+40.00%)
Want to see TSE:QAI full AI Analyst Report?
Predictmedix (QAI) Ratios
8 Followers
Predictmedix Ratios
TSE:QAI's free cash flow for Q3 2025 was C$-31.76K. For the 2025 fiscal year, TSE:QAI's free cash flow was increased by C$0.00 and operating cash flow was C$-31.76K. See a summary of the company’s cash flow.
| Ratios | Apr 25 | Jan 24 | Apr 23 | Apr 22 | Apr 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.05 | 0.11 | 0.16 | 1.83 | 5.52 |
| Quick Ratio | 0.05 | 0.11 | 0.19 | 1.83 | 6.35 |
| Cash Ratio | 0.00 | 0.06 | 0.09 | 0.60 | 3.55 |
| Solvency Ratio | -0.70 | -2.92 | -2.19 | -5.16 | -14.26 |
| Operating Cash Flow Ratio | -0.03 | -2.63 | -0.61 | -4.38 | -7.98 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | -14.11 | 0.00 | 0.00 |
| Net Current Asset Value | C$ -1.39M | C$ -556.44K | C$ -733.64K | C$ 291.95K | C$ 612.09K |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.05 | 0.00 | 0.02 |
| Debt-to-Equity Ratio | 0.00 | 0.00 | -0.25 | 0.00 | 0.02 |
| Debt-to-Capital Ratio | 0.00 | 0.00 | -0.33 | 0.00 | 0.02 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | -0.10 | -3.35 | -4.68 | 1.39 | 1.16 |
| Debt Service Coverage Ratio | 0.00 | -201.47 | -43.89 | 0.00 | 0.00 |
| Interest Coverage Ratio | 0.00 | -212.10 | -678.53 | 0.00 | 0.00 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Debt to EBITDA | 0.00 | 0.02 | 0.02 | 0.12 | 0.25 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 76.01% | 62.91% | 0.00% |
| EBIT Margin | 0.00% | 0.00% | -5896.31% | -1396.07% | 0.00% |
| EBITDA Margin | 0.00% | 0.00% | -5440.98% | -1337.26% | 0.00% |
| Operating Profit Margin | 0.00% | 0.00% | -5560.75% | -1284.40% | 0.00% |
| Pretax Profit Margin | 0.00% | 0.00% | -5904.50% | -1396.07% | 0.00% |
| Net Profit Margin | 0.00% | 0.00% | -5904.50% | -1396.07% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | -5904.50% | -1396.07% | 0.00% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.14% |
| EBT Per EBIT | 149.18% | 104.22% | 106.18% | 108.69% | 100.00% |
| Return on Assets (ROA) | -891.04% | -414.16% | -288.09% | -152.20% | -192.65% |
| Return on Equity (ROE) | 89.10% | 1386.11% | 1348.05% | -212.20% | -222.69% |
| Return on Capital Employed (ROCE) | 59.73% | 1329.96% | 1269.57% | -195.23% | -222.37% |
| Return on Invested Capital (ROIC) | 59.73% | 1329.96% | 1589.96% | -179.61% | -222.04% |
| Return on Tangible Assets | -891.04% | -1223.85% | -760.13% | -262.19% | -255.89% |
| Earnings Yield | -52.16% | -23.25% | -25.87% | -14.53% | -6.82% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.91 | 0.35 | 0.00 |
| Payables Turnover | 0.12 | 0.30 | 0.01 | 0.15 | 0.03 |
| Inventory Turnover | 0.00 | 0.00 | -0.32 | 50000.00 | -0.03 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.26 | 1.77 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.05 | 0.11 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | -0.16 | 0.30 | 0.00 |
| Cash Conversion Cycle | -3098.11 | -1228.31 | -36934.70 | -1409.93 | -25724.33 |
| Days of Sales Outstanding | 0.00 | 0.00 | 401.15 | 1031.56 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | -1128.98 | 0.01 | -11645.05 |
| Days of Payables Outstanding | 3098.11 | 1228.31 | 36206.87 | 2441.50 | 14079.28 |
| Operating Cycle | 0.00 | 0.00 | -727.83 | 1031.57 | -11645.05 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.00 | -0.01 | -0.00 | -0.01 | -0.01 |
| Free Cash Flow Per Share | -0.00 | -0.01 | -0.01 | -0.02 | -0.01 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | -821504.00 | -3.69 | -3.66 | -5.54 |
| Capital Expenditure Coverage Ratio | 0.00 | -821504.00 | -3.69 | -3.66 | -5.54 |
| Operating Cash Flow Coverage Ratio | 0.00 | 0.00 | -14.11 | 0.00 | -71.08 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | -15.25 | -11.37 | 0.00 |
| Free Cash Flow Yield | -1.64% | -19.16% | -8.49% | -15.06% | -4.50% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -1.92 | -4.30 | -3.86 | -6.88 | -14.65 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 228.21 | 96.06 | 0.00 |
| Price-to-Book (P/B) Ratio | -1.71 | -59.63 | -52.10 | 14.60 | 32.63 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -61.13 | -5.22 | -11.77 | -6.64 | -22.23 |
| Price-to-Operating Cash Flow Ratio | -61.13 | -5.22 | -14.96 | -8.45 | -26.24 |
| Price-to-Earnings Growth (PEG) Ratio | 0.04 | 0.19 | -0.96 | 0.77 | 0.78 |
| Enterprise Value Multiple | -2.86 | -4.70 | -4.17 | -7.07 | -14.91 |
| Enterprise Value | 2.25M | 8.54M | 7.95M | 12.74M | 27.87M |
| EV to EBITDA | -2.86 | -4.70 | -4.17 | -7.07 | -14.91 |
| EV to Sales | 0.00 | 0.00 | 227.02 | 94.49 | 0.00 |
| EV to Free Cash Flow | -61.13 | -5.20 | -11.71 | -6.53 | -21.86 |
| EV to Operating Cash Flow | -61.13 | -5.20 | -14.88 | -8.31 | -25.81 |
| Tangible Book Value Per Share | -0.01 | -0.00 | -0.01 | 0.00 | 0.01 |
| Shareholders’ Equity Per Share | -0.01 | -0.00 | -0.00 | 0.01 | 0.01 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.06 | 0.08 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -0.01 | -0.01 | -0.02 | -0.02 | -0.02 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.25 | 1.00 | 1.00 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 2.36 | 0.54 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 44.41 | 9.69 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 10.01 | 1.36 | 0.00 |
| Income Quality | 0.03 | 0.82 | 0.26 | 0.81 | 0.68 |
Currency in CAD
